NCT01082692View on ClinicalTrials.gov

Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
HIV-1 InfectionHIV Infections
Interventions
BIOLOGICAL

PENNVAX-B

DNA plasmids delivered via IM injection + electroporation using CELLECTRA device

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors
All Listed Sponsors
lead

Inovio Pharmaceuticals

INDUSTRY

NCT01082692 - Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants | Biotech Hunter | Biotech Hunter